Compugen Ltd. (CGEN)
NASDAQ·Healthcare·Biotechnology
$2.73
-6.51%
Mkt Cap $201.10M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 2, 2026 | $2.16M | $67.33M | +3018.19% | -$0.07 | $0.60 | +957.14% | — | — |
| Q4 2025 Nov 10, 2025 | $14.30M | $1.89M | -86.77% | -$0.09 | -$0.07 | +22.22% | — | — |
| Q3 2025 Aug 6, 2025 | $1.47M | $1.26M | -14.45% | -$0.07 | -$0.08 | -14.29% | — | — |
| Q2 2025 May 19, 2025 | $3.70M | $2.28M | -38.34% | -$0.06 | -$0.08 | -33.33% | — | — |
| Q1 2025 Mar 4, 2025 | $5.00M | $1.47M | -70.58% | $0.07 | -$0.07 | -200.00% | — | — |
| Q4 2024 Nov 12, 2024 | $17.86M | $17.13M | -4.08% | $0.06 | $0.01 | -83.33% | — | — |
| Q3 2024 Aug 6, 2024 | $2.49M | $6.70M | +169.16% | -$0.08 | -$0.02 | +75.00% | — | — |
| Q2 2024 May 20, 2024 | $6.21M | $2.56M | -58.79% | -$0.10 | -$0.08 | +20.00% | — | — |
| Q1 2024 Mar 5, 2024 | $20.00M | $33.46M | +67.30% | $0.23 | $0.11 | -52.17% | — | — |
| Q4 2023 Nov 7, 2023 | $16.85M | $8.00M | -52.52% | -$0.09 | -$0.11 | -22.22% | — | — |
| Q3 2023 Aug 7, 2023 | — | — | — | -$0.13 | -$0.11 | +15.38% | — | — |
| Q2 2023 May 15, 2023 | — | — | — | -$0.12 | -$0.11 | +8.33% | — | — |
| Q1 2023 Feb 27, 2023 | — | $7.50M | — | -$0.14 | -$0.04 | +71.43% | — | — |
| Q4 2022 Nov 14, 2022 | — | — | — | -$0.13 | -$0.14 | -7.69% | — | — |
| Q3 2022 Aug 4, 2022 | — | — | — | -$0.12 | -$0.11 | +8.33% | — | — |
| Q2 2022 May 16, 2022 | — | — | — | -$0.12 | -$0.11 | +8.33% | — | — |
| Q1 2022 Feb 24, 2022 | $1.00M | -$5.15M | -615.10% | -$0.15 | -$0.10 | +33.33% | — | — |
| Q4 2021 Nov 12, 2021 | $7.65M | $6.00M | -21.57% | -$0.13 | -$0.07 | +46.15% | — | — |
| Q3 2021 Jul 28, 2021 | — | — | — | -$0.12 | -$0.11 | +8.33% | — | — |
| Q2 2021 May 13, 2021 | — | — | — | -$0.12 | -$0.12 | +0.00% | — | — |